ASK REDCHAT ANYTHING ABOUT KYVERNA THERAPEUTICS INC.
Kyverna Therapeutics Inc. (NASDAQ: KYTX)
Listen to this Section
$8.20
N/A
(
0% )
1.5K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| KYV-101DetailsLupus nephritis |
Phase 1 |
Market Data
|
| Open |
$8.20 |
| Previous Close |
$8.20 |
| Volume |
1.5K |
| Market Cap |
$524.06M |
| Day Range |
$8.29 - $8.68 |
| 52 Week Range |
$2.52 - $13.67 |
| Shares Outstanding |
60.80M |
| Change % |
0% |
| Net Change |
N/A |
| Insider Ownership |
-0.27% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | |
| IPO Year | 2024 |
| Country | United States |
| Underwriter | J.P. Morgan, Morgan Stanley, Leerink Partners, Wells Fargo Securities, more |
Insider Ownership Transactions
Total Amount Purchased:
1,139,027.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-06-10 |
Sale |
-9636.00 |
Walker Karen Marie |
| 2024-05-29 |
Sale |
-10870.00 |
Jones Ryan Alexander |
| 2024-02-14 |
Buy |
2713868.00 |
Bain Capital Life Sciences Investors, LLC |
| 2024-02-14 |
Sale |
-3787940.00 |
SEIDENBERG BETH C |
| 2024-02-14 |
Sale |
-4523924.00 |
Cohen Fred E |
| 2024-02-14 |
Buy |
4523924.00 |
Vida Ventures, LLC |
| 2024-02-14 |
Sale |
-3787940.00 |
Westlake BioPartners Fund I, L.P. |
| 2024-02-13 |
Buy |
3216119.00 |
GILEAD SCIENCES, INC. |
| 2024-02-12 |
Buy |
2805426.00 |
Northpond Ventures III GP, LLC |